Neurodegenerative Drugs Market is Expected to Register a Considerable Growth by 2028

The Neurodegenerative Drugs Market was estimated to grow from USD 41.91 billion in 2021 to USD 67.08 billion by 2028 at a CAGR of around 6.91% during the forecast period.


The Neurodegenerative Drugs is segmented, By Type (N-Methyl-D-Aspartic Acid (NMDA), Selective Serotonin Reuptake Inhibitors (SSRIs), Dopamine Inhibitors, Other), Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA), Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online), and Region - (North America, Europe, Asia-Pacific, and Rest of the World).

What is neurodegenerative disease?

Neurodegenerative disease is defined as a group of diseases that affects the neurons in the human brain. The inability of neurons to reproduce themselves results in the development of neurodegenerative diseases. Neurodegenerative diseases include multiple sclerosis, Parkinson's disease, Alzheimer's disease, spinal muscular atrophy (SMA), and others.

Key Players

Key players operating in the neurodegenerative drugs market are-

  • Novartis International AG (Switzerland)
  • Pfizer Inc. (US)
  • Merck Serono (Germany)
  • Biogen Inc. (US)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Benetton Group S.r.l. (Italy)
  • C.H. Boehringer Sohn AG Ko. KG (Germany)
  • Sanofi S.A. (France)
  • GlaxoSmithKline plc (UK).

Market Dynamics

The growth of the neurodegenerative drugs market is primarily driven by the increasing prevalence of Alzheimer's and Parkinson's diseases. Expanding the geriatric populace across geographies is likely to drive market growth at a significant rate during the review period. In addition to this, increasing investment in research and development activities to develop new treatment methods is likely to create lucrative opportunities for the players operating in the global neurodegenerative drugs market in the coming years.

Report Customization

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

  • Detailed profiling of additional market players (up to three players)
  • SWOT analysis of key players (up to three players)

Competitive Benchmarking

  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at [email protected].